He will oversee the company’s psychiatry and mental wellness strategy. Dr. Lieberman will also focus on expanding personalized anxiety and depression treatments.
Prior to joining Hims & Hers, he served as a clinical professor of psychiatry and behavioral sciences at George Washington (D.C.) University. He has advised the Department of Commerce and the Office of Drug & Alcohol Policy & Compliance on psychiatric topics.
Hims & Hers Health surpassed 1 million subscribers and reported $527 million in revenue in Q4 2022, a 94 percent year-over-year increase.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
